Sphera Funds Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Sphera Funds Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,000	Closed	-$516K	–	105
2019 Q4	$516K	Sell	40,000 -35,000	-47%	-$323K	0.04%	83
2019 Q3	$788K	Buy	+75,000	New	+$980K	0.12%	73
2017 Q3	–	Sell	-25,000	Closed	-$2.92M	–	153
2017 Q2	$2.92M	Buy	25,000 +5,000	+25%	+$621K	0.5%	61
2017 Q1	$2.47M	Buy	+20,000	New	+$2.62M	0.48%	61
2016 Q1	–	Sell	-23,152	Closed	-$4.69M	–	127
2015 Q4	$4.69M	Buy	23,152 +1	+0%	+$179	0.69%	25
2015 Q3	$3.36M	Hold	23,151	–	–	0.43%	49
2015 Q2	$4.92M	Sell	23,151 -1,806	-7%	-$443K	0.48%	46
2015 Q1	$5.69M	Sell	24,957 -8,194	-25%	-$1.98M	0.59%	34
2014 Q4	$6.96M	Buy	+33,151	New	+$7.11M	1.19%	19

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sphera Funds Management's BLCM Position: Q1 2020 in Review

Sphera Funds Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2020, closing a stake of 40,000 shares — an estimated $516K sold.

Sphera Funds Management first reported a position in BLCM in Q4 2014 and held it in 9 quarters. The position peaked at $6.96M in Q4 2014. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2020.

Sphera Funds Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Sphera Funds Management sold 40,000 Bellicum Pharmaceuticals, Inc. shares in Q1 2020, an estimated $516K.
Sphera Funds Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 9 quarters.
Sphera Funds Management's Bellicum Pharmaceuticals, Inc. position peaked at $6.96M in Q4 2014.
29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2020.

Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.